Antisense Delivery

We have collected information about Antisense Delivery for you. Follow the links to find out details on Antisense Delivery.


A Self-Assembled Platform Based on Branched DNA for sgRNA ...

    https://pubs.acs.org/doi/10.1021/jacs.9b09043
    Precisely assembled DNA nanostructures are promising candidates for the delivery of biomolecule-based therapeutics. Herein, we introduce a facile strategy for the construction of a branched DNA-based nanoplatform for codelivery of gene editing (sgRNA/Cas9, targeting DNA in the nucleus) and gene silencing (antisense, targeting mRNA in the cytoplasm) components for synergistic tumor therapy in ...Author: Jianbing Liu, Tiantian Wu, Tiantian Wu, Xuehe Lu, Xuehe Lu, Xiaohui Wu, Xiaohui Wu, Shaoli Liu, Shao...

Antisense oligonucleotides: the next frontier for ...

    https://www.nature.com/articles/nrneurol.2017.148
    Dec 01, 2017 · Falzarano, M. S., Passarelli, C. & Ferlini, A. Nanoparticle delivery of antisense oligonucleotides and their application in the exon skipping strategy for Duchenne muscular dystrophy.Author: C Rinaldi, Wood Mja.

Systemic Brain Delivery of Antisense Oligonucleotides ...

    https://onlinelibrary.wiley.com/doi/abs/10.1002/anie.201914751
    Jan 29, 2020 · Systemic Brain Delivery of Antisense Oligonucleotides across the Blood–Brain Barrier with a Glucose‐Coated Polymeric Nanocarrier. Dr. Hyun Su Min. Department of Materials Engineering, Graduate School of Engineering, The University of Tokyo, …Author: Hyun Su Min, Hyun Jin Kim, Mitsuru Naito, Satomi Ogura, Kazuko Toh, Kotaro Hayashi, Beob Soo Kim, Sh...

Antisense oligonucleotides in therapy for ...

    https://www.sciencedirect.com/science/article/pii/S0169409X15000435
    In rats, intranasal delivery of antisense oligonucleotides was found to lead to good distribution throughout the brain, and was able to slow down intracerebral tumour growth . These studies hence indicate that intranasal delivery may become a viable option for antisense oligonucleotide delivery in the future. 3. Chemical modificationsAuthor: Melvin M. Evers, Lodewijk J.A. Toonen, Willeke M.C. van Roon-Mom

Bolaamphiphile-based nanocomplex delivery of ...

    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4975145/
    Aug 01, 2016 · The application of antisense inhibition to bacterial cells is an attractive alternative to conventional antibiotics but presents a particular challenge in requiring efficient delivery of antisense molecules across bacterial cell envelopes.Author: John P Hegarty, Jacek Krzeminski, Arun K Sharma, Diana Guzman-Villanueva, Volkmar Weissig, David B S...

Gene silencing by gold nanoshell-mediated delivery and ...

    https://www.ncbi.nlm.nih.gov/pubmed/22862291
    Sep 25, 2012 · Gene silencing by gold nanoshell-mediated delivery and laser-triggered release of antisense oligonucleotide and siRNA. Huschka R(1), Barhoumi A, Liu Q, Roth JA, Ji L, Halas NJ. Author information: (1)Department of Chemistry, Rice University, …Author: Ryan Huschka, Aoune Barhoumi, Qing Liu, Jack A. Roth, Lin Ji, Naomi J. Halas

Delivery of Antisense RNA Therapeutics

    https://antisenserna.eu/
    The Delivery of Antisense RNA ThERapeutics (DARTER) Action Members is a highly dedicated group of scientists, whose goal is (through COST networking tools) to allow RNA-targeting nucleic acid drugs to reach their full potential and become a mainstream therapeutic option. Antisense oligonucleotides (ASOs) are a new class of drugs that, through very specific targeting, could correct genetic ...

Local delivery of an antisense oligonucleotide for ...

    https://www.proqr.com/wp-content/uploads/downloads/2017/09/ProQR_QR-313_Local-delivery.pdf
    Local delivery of an antisense oligonucleotide for recessive dystrophic epidermolysis bullosa R Mendes, L van Wissen, MW de Jager, F van der Ham, V Brinks, T Ritsema, EM Haisma ProQR Therapeutics N.V. Leiden, the Netherlands Results (continued) Next delivery …

Efficient Delivery of Antisense Oligonucleotides Using ...

    https://www.sciencedirect.com/science/article/pii/S2162253120300536
    The efficient delivery of antisense oligonucleotides (ASOs) to the targeted cells and organs remains a challenge, in particular, in vivo.Here, we investigated the ability of a library of biodegradable lipid nanoparticles (LNPs) in delivering ASO to both cultured human cells and animal models.Author: Liu Yang, Feihe Ma, Fang Liu, Jinjin Chen, Xuewei Zhao, Qiaobing Xu

Searching for Antisense Delivery?

You can just click the links above. The data is collected for you.

Related Delivery Info